<a href="https://laohu8.com/S/XTNT">Xtant Medical Holdings Inc</a>. Announces Date for Annual Stockholders Meeting
Xtant Medical Holdings Inc. has scheduled its Annual Meeting of Stockholders for November 7, 2025, at the offices of Fox Rothschild LLP in New York, New York. During the meeting, stockholders will vote on several key proposals. These include the election of six nominees to serve as directors until the next annual meeting, the ratification of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2025, and the approval of an amendment to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan to increase the number of shares available under the plan by 12,300,000 shares. Additionally, stockholders will vote on an advisory basis regarding the compensation of executive officers and the frequency of future advisory votes on executive compensation. Other business may also be transacted during the meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtant Medical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-013361), on September 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.